Hualan Biological Vaccine Inc.

¥15.42As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301207Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (16.31%)
Div yield 10.38%
ROE 0.85%
Biotechnology
Beta (5Y) 0.71
PE TTM 198.4
TSR TTM (26.40%)
Mkt cap ¥9.175B
ROIC (2.82%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
3.05%
(19.70%)
Sell 2|6|2|0|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.18
0.18
0.19
0.21
11.86%
4.86%
6.09%
13.43%
Revenue¥M
575.0
566.9
576.7
562.9
11.73%
4.20%
3.45%
(2.10%)
Peers (US$1.375B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.358
5.609
3.606
EBIT/Intx
0.740
0.365
0.358
Own earn%
69.73
62.44
77.53
Sh yield%
8.42
40.82
40.65
Owners
Insiders/Inst%
10.58
64.78
Short interest%
5.13
SBC / revenue%
0.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
21–26
$1 testx
—
Incr. ROIC%
2